Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
It appears not just unfair, but absurdly so. The US government paid for research that produced a patented drug, the patents were licensed exclusively to a Japanese firm, and that firm is now
SHANGHAI, May 19 (Xinhua) -- Eleven people went on trial Thursday accused of manufacturing and selling a fake eye medication that left 61 people suffering from adverse reactions in Shanghai. Luwan Dis...
Jan 25 (Reuters) - The leading U.S. generic drug industry group said Thursday that it is asking a court to block Illinois from enforcing a state law capping price increases for certain generic drugs.
When the deadline approaches, the companies patent an improvement on the drug - sometimes just a small step - which grants another 20 years," Jia said. So far, compulsory licenses have never been
Prior to its launch of a new drug treating male hair loss, Henan Topfond Pharmaceutical found Merck patented the process of making the drug 10 years ago. Hanging in for four years of exhaustive legal
will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices. "We'll make it clear that
, California-based Amgen told the court on Monday that Samsung had applied for permission from the U.S. Food and Drug Administration to market biosimilars of Prolia, which treats patients suffering from
Oct 7 (Reuters) - Novo Nordisk (NOVOb.CO) and Viatris (VTRS.O) have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and Wegovy, the companies told a U.S. Pat...
Aug 14 (Reuters) - AstraZeneca (AZN.L) on Wednesday convinced a federal judge in Delaware to throw out a jury's decision that the company owes $107.5 million for infringing cancer-drug patents
versions of the HIV prevention drug Lenacapavir in 120 low- and middle-income countries. Among these countries is India which has the biggest generic drug industry outside the U.S. Lenacapavir has been
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
